Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1993 Jun;61(6):2639–2643. doi: 10.1128/iai.61.6.2639-2643.1993

Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes.

A Lundén 1, K Lövgren 1, A Uggla 1, F G Araujo 1
PMCID: PMC280895  PMID: 8500902

Abstract

Immunostimulating complexes were prepared with antigens extracted from tachyzoites of Toxoplasma gondii and were used to immunize mice. The major antigens incorporated into the immunostimulating complexes were the P30 and P22 antigens and an antigen with an approximate molecular weight of 6,000. Other antigens of molecular weights above 30,000 were also present. High antibody titers to T. gondii antigens and a delayed-type hypersensitivity reaction were noted for the immunized mice. Challenge of these mice with tachyzoites injected interperitoneally or with oocysts administered orally resulted in a statistically significant (P < 0.001) conditional probability of survival compared with that of controls. In contrast, the differences between immunized mice and controls challenged with tissue cysts did not attain statistical significance.

Full text

PDF
2639

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buxton D., Thomson K., Maley S., Wright S., Bos H. J. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet Rec. 1991 Aug 3;129(5):89–93. doi: 10.1136/vr.129.5.89. [DOI] [PubMed] [Google Scholar]
  2. Buxton D., Uggla A., Lövgren K., Thomson K., Lundén A., Morein B., Blewett D. A. Trial of a novel experimental Toxoplasma iscom vaccine in pregnant sheep. Br Vet J. 1989 Sep-Oct;145(5):451–457. doi: 10.1016/0007-1935(89)90053-5. [DOI] [PubMed] [Google Scholar]
  3. Bülow R., Boothroyd J. C. Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J Immunol. 1991 Nov 15;147(10):3496–3500. [PubMed] [Google Scholar]
  4. Couvreur G., Sadak A., Fortier B., Dubremetz J. F. Surface antigens of Toxoplasma gondii. Parasitology. 1988 Aug;97(Pt 1):1–10. doi: 10.1017/s0031182000066695. [DOI] [PubMed] [Google Scholar]
  5. Frenkel J. K. Pathophysiology of toxoplasmosis. Parasitol Today. 1988 Oct;4(10):273–278. doi: 10.1016/0169-4758(88)90018-x. [DOI] [PubMed] [Google Scholar]
  6. Handman E., Goding J. W., Remington J. S. Detection and characterization of membrane antigens of Toxoplasma gondii. J Immunol. 1980 Jun;124(6):2578–2583. [PubMed] [Google Scholar]
  7. Handman E., Remington J. S. Serological and immunochemical characterization of monoclonal antibodies to Toxoplasma gondii. Immunology. 1980 Aug;40(4):579–588. [PMC free article] [PubMed] [Google Scholar]
  8. Huskinson J., Stepick-Biek P. N., Araujo F. G., Thulliez P., Suzuki Y., Remington J. S. Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection. J Clin Microbiol. 1989 Sep;27(9):2031–2038. doi: 10.1128/jcm.27.9.2031-2038.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Israelski D. M., Remington J. S. Toxoplasmic encephalitis in patients with AIDS. Infect Dis Clin North Am. 1988 Jun;2(2):429–445. [PubMed] [Google Scholar]
  10. Kasper L. H., Bradley M. S., Pfefferkorn E. R. Identification of stage-specific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies. J Immunol. 1984 Jan;132(1):443–449. [PubMed] [Google Scholar]
  11. Kasper L. H. Identification of stage-specific antigens of Toxoplasma gondii. Infect Immun. 1989 Mar;57(3):668–672. doi: 10.1128/iai.57.3.668-672.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Khan I. A., Ely K. H., Kasper L. H. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice. J Immunol. 1991 Nov 15;147(10):3501–3506. [PubMed] [Google Scholar]
  13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  14. Lunde M. N., Jacobs L. Antigenic differences between endozoites and cystozoites of Toxoplasma gondii. J Parasitol. 1983 Oct;69(5):806–808. [PubMed] [Google Scholar]
  15. Lövgren K., Morein B. The requirement of lipids for the formation of immunostimulating complexes (iscoms). Biotechnol Appl Biochem. 1988 Apr;10(2):161–172. [PubMed] [Google Scholar]
  16. Lövgren K., Uggla A., Morein B. A new approach to the preparation of a Toxoplasma gondii membrane antigen for use in ELISA. Zentralbl Veterinarmed B. 1987 Jun;34(4):274–282. doi: 10.1111/j.1439-0450.1987.tb00397.x. [DOI] [PubMed] [Google Scholar]
  17. Morein B., Ekström J., Lövgren K. Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms. J Immunol Methods. 1990 Apr 17;128(2):177–181. doi: 10.1016/0022-1759(90)90208-d. [DOI] [PubMed] [Google Scholar]
  18. Mowat A. M., Donachie A. M., Reid G., Jarrett O. Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology. 1991 Mar;72(3):317–322. [PMC free article] [PubMed] [Google Scholar]
  19. Overnes G., Nesse L. L., Waldeland H., Lövgren K., Gudding R. Immune response after immunization with an experimental Toxoplasma gondii ISCOM vaccine. Vaccine. 1991 Jan;9(1):25–28. doi: 10.1016/0264-410x(91)90312-t. [DOI] [PubMed] [Google Scholar]
  20. Prince J. B., Auer K. L., Huskinson J., Parmley S. F., Araujo F. G., Remington J. S. Cloning, expression, and cDNA sequence of surface antigen P22 from Toxoplasma gondii. Mol Biochem Parasitol. 1990 Nov;43(1):97–106. doi: 10.1016/0166-6851(90)90134-8. [DOI] [PubMed] [Google Scholar]
  21. Sharma S. D., Mullenax J., Araujo F. G., Erlich H. A., Remington J. S. Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol. 1983 Aug;131(2):977–983. [PubMed] [Google Scholar]
  22. Sjölander A., Lövgren K., Ståhl S., Aslund L., Hansson M., Nygren P. A., Larsson M., Hagstedt M., Wåhlin B., Berzins K. High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. Vaccine. 1991 Jun;9(6):443–450. doi: 10.1016/0264-410x(91)90133-q. [DOI] [PubMed] [Google Scholar]
  23. Suzuki Y., Remington J. S. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol. 1988 Jun 1;140(11):3943–3946. [PubMed] [Google Scholar]
  24. Takahashi H., Takeshita T., Morein B., Putney S., Germain R. N., Berzofsky J. A. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature. 1990 Apr 26;344(6269):873–875. doi: 10.1038/344873a0. [DOI] [PubMed] [Google Scholar]
  25. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Uggla A., Araujo F. G., Lunden A., Lövgren K., Remington J. S., Morein B. Immunizing effects in mice of two Toxoplasma gondii iscom preparations. Zentralbl Veterinarmed B. 1988 May;35(4):311–314. doi: 10.1111/j.1439-0450.1988.tb00501.x. [DOI] [PubMed] [Google Scholar]
  27. Ware P. L., Kasper L. H. Strain-specific antigens of Toxoplasma gondii. Infect Immun. 1987 Mar;55(3):778–783. doi: 10.1128/iai.55.3.778-783.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Weiss L. M., Udem S. A., Tanowitz H., Wittner M. Western blot analysis of the antibody response of patients with AIDS and toxoplasma encephalitis: antigenic diversity among Toxoplasma strains. J Infect Dis. 1988 Jan;157(1):7–13. doi: 10.1093/infdis/157.1.7. [DOI] [PubMed] [Google Scholar]
  29. Wilkins M. F., O'Connell E., Te Punga W. A. Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge. N Z Vet J. 1988 Jun;36(2):86–89. doi: 10.1080/00480169.1988.35489. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES